Washington: US today congratulated India for developing an indigenous rotavirus vaccine for prevention of diarrhoea, terming it a significant victory for the country`s scientific community. The Government of India`s Department of Biotechnology (DBT) and Bharat Biotech yesterday announced positive results from a Phase III clinical trial of a rotavirus vaccine developed and manufactured in India. "We congratulate the Programme for Appropriate Technology in Health (PATH), Bharat Biotech International, Ltd, and the scientists, government and people of India on the important results from the ROTAVAC rotavirus vaccine study," Anthony S Fauci of National Institute of Allergy and Infectious Diseases (NIAID) said in a statement. "Highly contagious rotaviruses are the leading cause of severe diarrheal illnesses among infants and young children in both developed and resource-limited countries. Each year, rotavirus-induced diarrheal disease kills roughly 435,000 children younger than 5 years old and hospitalises an estimated two million children worldwide, largely in developing countries," he said.
Smriti Irani files nomination from Amethi
Srinivasan should be kept out of BCCI affairs: SC
61st National Film Awards announced
Ananth Kumar calls Congress a non-performer across India